196 related articles for article (PubMed ID: 24275374)
1. Microsporum spp. onychomycosis: disease presentation, risk factors and treatment responses in an urban population.
Martínez E; Ameen M; Tejada D; Arenas R
Braz J Infect Dis; 2014; 18(2):181-6. PubMed ID: 24275374
[TBL] [Abstract][Full Text] [Related]
2. Fusarium onychomycosis: prevalence, clinical presentations, response to itraconazole and terbinafine pulse therapy, and 1-year follow-up in nine cases.
Ranawaka RR; Nagahawatte A; Gunasekara TA
Int J Dermatol; 2015 Nov; 54(11):1275-82. PubMed ID: 26223159
[TBL] [Abstract][Full Text] [Related]
3. Onychomycosis due to Microsporum gypseum.
Romano C
Mycoses; 1998; 41(7-8):349-51. PubMed ID: 9861844
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
Gupta AK; Gregurek-Novak T
Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
[TBL] [Abstract][Full Text] [Related]
5. Case report. Onychomycosis due to Microsporum canis.
Romano C; Paccagnini E; Pelliccia L
Mycoses; 2001 May; 44(3-4):119-20. PubMed ID: 11413924
[TBL] [Abstract][Full Text] [Related]
6. Non-dermatophytic onychomycosis. An understimated entity? A study of 51 cases.
Gianni C; Cerri A; Crosti C
Mycoses; 2000; 43(1-2):29-33. PubMed ID: 10838843
[TBL] [Abstract][Full Text] [Related]
7. Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients.
Ginter-Hanselmayer G; Weger W; Smolle J
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):470-5. PubMed ID: 18194238
[TBL] [Abstract][Full Text] [Related]
8. Itraconazole and terbinafine treatment of some nondermatophyte molds causing onychomycosis of the toes and a review of the literature.
Gupta AK; Gregurek-Novak T; Konnikov N; Lynde CW; Hofstader S; Summerbell RC
J Cutan Med Surg; 2001; 5(3):206-10. PubMed ID: 11685666
[TBL] [Abstract][Full Text] [Related]
9. Proximal white subungual onychomycosis caused by Microsporum canis in systemic lupus erythematosus.
Tlacuilo-Parra A; Guevara-Gutiérrez E; Mayorga J; Salazar-Páramo M
Rheumatol Int; 2002 Apr; 21(6):250-2. PubMed ID: 12036214
[TBL] [Abstract][Full Text] [Related]
10. In vitro antifungal susceptibility testing of fungi in patients with onychomycosis.
Abu El-Hamd M; Abd Elhameed MI; Shalaby MFM; Saleh R
Dermatol Ther; 2020 May; 33(3):e13429. PubMed ID: 32304603
[TBL] [Abstract][Full Text] [Related]
11. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
Arca E; Taştan HB; Akar A; Kurumlu Z; Gür AR
J Dermatolog Treat; 2002 Mar; 13(1):3-9. PubMed ID: 12006131
[TBL] [Abstract][Full Text] [Related]
12. Fingernail onychomycosis caused by Microsporum canis in a teenager.
Limphoka P; Bunyaratavej S; Leeyaphan C
Pediatr Dermatol; 2021 Mar; 38(2):524-525. PubMed ID: 33481262
[TBL] [Abstract][Full Text] [Related]
13. Long-term results in patients with onychomycosis treated with terbinafine or itraconazole.
Heikkilä H; Stubb S
Br J Dermatol; 2002 Feb; 146(2):250-3. PubMed ID: 11903235
[TBL] [Abstract][Full Text] [Related]
14. The prevalence, aetiological agents and therapy of onychomycosis in patients with psoriasis: a prospective controlled trial.
Kaçar N; Ergin S; Ergin C; Erdogan BS; Kaleli I
Clin Exp Dermatol; 2007 Jan; 32(1):1-5. PubMed ID: 16824053
[TBL] [Abstract][Full Text] [Related]
15. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
Gupta AK
J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
[TBL] [Abstract][Full Text] [Related]
16. Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents.
Baudraz-Rosselet F; Ruffieux C; Lurati M; Bontems O; Monod M
Dermatology; 2010; 220(2):164-8. PubMed ID: 20110639
[TBL] [Abstract][Full Text] [Related]
17. Proximal subungual hyperkeratosis of the big toe due to Microsporum gypseum.
Romano C; Massai L
Acta Derm Venereol; 2001; 81(5):371-2. PubMed ID: 11800151
[No Abstract] [Full Text] [Related]
18. Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up.
Tosti A; Piraccini BM; Stinchi C; Colombo MD
Dermatology; 1998; 197(2):162-6. PubMed ID: 9732167
[TBL] [Abstract][Full Text] [Related]
19. Case Report of Onychomycosis and Tinea Corporis Due to Microsporum gypseum.
Fike JM; Kollipara R; Alkul S; Stetson CL
J Cutan Med Surg; 2018; 22(1):94-96. PubMed ID: 28817957
[TBL] [Abstract][Full Text] [Related]
20. Onychomycosis: pathogenesis, diagnosis, and management.
Elewski BE
Clin Microbiol Rev; 1998 Jul; 11(3):415-29. PubMed ID: 9665975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
